BEN SESSA

Ben Sessa
Consultant Psychiatrist

Ben trained at UCL, London, graduating in medicine in 1997. He works clinically and academically in Bristol and at Imperial College London University, with an interest in the developmental trajectory from child maltreatment to adult mental health disorders. In the last ten years Ben has been a study doctor and a test subject administering and receiving legal doses of pure LSD, psilocybin, MDMA, DMT and Ketamine. He is currently conducting the world’s first clinical study using MDMA to treat addiction.

Ben authors peer-reviewed articles in the mainstream medical press and has published several textbooks on psychedelic medicine and a novel. An outspoken critic of the current system by which drugs are prohibited, he believes a more progressive policy of regulation would reduce the harms of drug use, increase access to services and provide more opportunities for psychedelic research. He is a co-founder of Breaking Convention.

MDMA Therapy: A Child Psychiatrist’s Perspective
As a clinical child psychiatrist I take a developmental perspective to adult mental disorder and addictions. My work with abused children, seeing them grow into damaged and addicted adults, has brought me to the door of MDMA Therapy as psychiatry’s best opportunity for a therapeutic breakthrough. I will illustrate my talk with two on-going MDMA studies that I am leading in the UK.